Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 25,014 | -292,882 | -19,717 | -215,187 | -54,010 |
| Other Working Capital | -50,029 | 102,065 | 15,167 | -136,597 | 46,295 |
| Other Operating Activity | 650,376 | 896,397 | 210,820 | 857,004 | 814,012 |
| Operating Cash Flow | $625,362 | $705,580 | $206,270 | $505,221 | $806,296 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -451,824 | -439,323 | -248,737 | -224,542 | -5,787 |
| Net Acquisitions | 139,143 | 85,794 | N/A | N/A | N/A |
| Purchase Of Investment | -18,761 | -25,146 | -3,033 | -3,742 | -79,086 |
| Other Investing Activity | -118,819 | -10,354 | -15,167 | 24,325 | 19,289 |
| Investing Cash Flow | $-450,260 | $-389,030 | $-266,938 | $-203,959 | $-65,584 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 103,185 | 5,917 | 203,237 | N/A | N/A |
| Debt Repayment | -903,647 | -1,270,635 | -109,202 | -260,095 | -555,534 |
| Common Stock Issued | 4,690 | 1,998,402 | N/A | N/A | N/A |
| Other Financing Activity | -9,380 | -62,127 | -3,033 | -1,871 | 0 |
| Financing Cash Flow | $-805,153 | $671,558 | $91,001 | $-261,966 | $-555,534 |
| Exchange Rate Effect | -9,380 | -8,875 | -31,851 | 7,485 | 3,858 |
| Beginning Cash Position | 1,278,864 | 230,756 | 238,121 | 246,997 | 65,584 |
| End Cash Position | 639,432 | 1,209,988 | 236,604 | 293,776 | 254,620 |
| Net Cash Flow | $-630,052 | $988,107 | $30,334 | $39,295 | $185,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | 625,362 | 705,580 | 206,270 | 505,221 | 806,296 |
| Capital Expenditure | -492,472 | -462,990 | -406,473 | -385,465 | -540,103 |
| Free Cash Flow | 132,889 | 242,589 | -200,203 | 119,756 | 266,193 |